Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1915 4
1948 1
1951 1
1953 2
1954 1
1955 2
1956 6
1957 3
1958 3
1961 10
1962 21
1963 34
1964 27
1965 36
1966 39
1967 65
1968 56
1969 48
1970 58
1971 70
1972 25
1973 27
1974 45
1975 43
1976 38
1977 66
1978 47
1979 57
1980 58
1981 74
1982 73
1983 69
1984 81
1985 114
1986 99
1987 110
1988 105
1989 108
1990 111
1991 94
1992 104
1993 119
1994 124
1995 125
1996 173
1997 155
1998 195
1999 225
2000 228
2001 237
2002 263
2003 247
2004 291
2005 327
2006 338
2007 311
2008 294
2009 308
2010 300
2011 366
2012 423
2013 426
2014 456
2015 467
2016 494
2017 485
2018 486
2019 522
2020 617
2021 711
2022 760
2023 707
2024 610
2025 38

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,600 results

Results by year

Filters applied: . Clear all
Page 1
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial.
Imai M, Nakamura Y, Shin S, Okamoto W, Kato T, Esaki T, Kato K, Komatsu Y, Yuki S, Masuishi T, Nishina T, Sawada K, Sato A, Kuwata T, Yamashita R, Fujisawa T, Bando H, Ock CY, Fujii S, Yoshino T. Imai M, et al. Among authors: kato t. JCO Precis Oncol. 2025 Jan;9:e2400385. doi: 10.1200/PO-24-00385. Epub 2025 Jan 17. JCO Precis Oncol. 2025. PMID: 39823559 Clinical Trial.
Influence of obtaining medical records and laboratory data on the sensitivity of diagnostic imaging assessment by radiological technologists.
Koori N, Kato T, Yamamoto S, Yasui M, Kurata K, Hasegawa T, Nishikawa F, Sugiyama M, Ishiguro R, Takamatsu Y, Higuchi M, Kobayashi H, Nakane H, Fuse H, Sasaki K, Miyakawa S, Yasue K, Takahashi M, Nosaka N. Koori N, et al. Among authors: kato t. Radiol Phys Technol. 2025 Jan 16. doi: 10.1007/s12194-025-00880-8. Online ahead of print. Radiol Phys Technol. 2025. PMID: 39821066
2023 National Clinical Database Annual Report by the Japan Surgical Society.
Yamamoto T, Takahashi A, Yoshizumi T, Ishihara S, Inomata M, Imoto S, Eguchi H, Ebata T, Otsuka M, Okuyama H, Kakeji Y, Kato T, Kamei T, Saiki Y, Saito A, Shimizu H, Soga Y, Tajiri T, Nogi H, Hatano E, Hara H, Bitoh Y, Mizushima T, Minatoya K, Miyagawa S, Yamauchi H, Yoshino I, Baba H, Matsubara H, Hasegawa K, Taketomi A. Yamamoto T, et al. Among authors: kato t. Surg Today. 2025 Jan 17. doi: 10.1007/s00595-024-02980-1. Online ahead of print. Surg Today. 2025. PMID: 39820660 No abstract available.
Real-world comparative outcomes and toxicities after definitive radiotherapy using proton beam therapy versus intensity-modulated radiation therapy for prostate cancer: a retrospective, single-institutional analysis.
Ishikawa Y, Suzuki M, Yamaguchi H, Seto I, Machida M, Takagawa Y, Azami Y, Dai Y, Sulaiman NS, Teramura S, Narita Y, Kato T, Kikuchi Y, Fukaya Y, Murakami M. Ishikawa Y, et al. Among authors: kato t. J Radiat Res. 2025 Jan 15:rrae065. doi: 10.1093/jrr/rrae065. Online ahead of print. J Radiat Res. 2025. PMID: 39812335 Free article.
Cost-Effectiveness of the Self-Care Management System for Heart Failure.
Nakane E, Kato T, Tanaka N, Idouji M, Yamamoto Y, Saitou W, Hamaguchi T, Yano M, Harita T, Yamaji Y, Fukuda H, Haruna T, Inoko M. Nakane E, et al. Among authors: kato t. Circ Rep. 2024 Dec 7;7(1):31-36. doi: 10.1253/circrep.CR-24-0088. eCollection 2025 Jan 10. Circ Rep. 2024. PMID: 39802132 Free PMC article.
The Efficacy of FOLFIRI Plus Ramucirumab in Recurrent Colorectal Cancer Refractory to Adjuvant Chemotherapy with Oxaliplatin/Fluoropyrimidine-Including Biomarker Analyses.
Sugimoto N, Noura S, Kato T, Yoshioka S, Hata T, Naito A, Tei M, Tamagawa H, Komori T, Ide Y, Fukuzaki T, Danno K, Sawada G, Kagawa Y, Shimokawa T, Miyoshi N, Ogino T, Uemura M, Yamamoto H, Murata K, Doki Y, Eguchi H. Sugimoto N, et al. Among authors: kato t. Cancers (Basel). 2024 Dec 30;17(1):91. doi: 10.3390/cancers17010091. Cancers (Basel). 2024. PMID: 39796720 Free PMC article.
12,600 results
You have reached the last available page of results. Please see the User Guide for more information.